Award details

Replication of infectivity in vitro

ReferenceBBS/E/I/00000657
Principal Investigator / Supervisor Dr James Hope
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 116,407
StatusCompleted
TypeInstitute Project
Start date 02/10/1997
End date 01/10/2000
Duration36 months

Abstract

On binding to PrPSc in vitro, PrPC becomes more resistant to hydrolysis, epitopes in its 90-120 region are masked and the altered 'PrPC' can be pelleted from solution in association with PrPSc. By these biophysical, biochemical and immunological criteria several which have long been used to define the infectious prion several the PrPC has been converted to PrPSc. If PrPSc is infectious then it should be possible to show the de novo production of infectivity by bioassay. Current failure to show 'new' infectious particles may reflect technical inadequacy or the inadequacy of the prion hypothesis itself. Novel methods of high- efficiency conversion and protein fractionation are in development to underpin future biological assay investigations of this idea.

Summary

unavailable
Committee Closed Committee - Agri-food (AF)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file